Industry News

NR: A Cardioprotective Booster via Glycolysis Activation in Low Insulin Settings
NR: A Cardioprotective Booster via Glycolysis Activation in Low Insulin Settings

  Introduction Nicotinamide adenine dinucleotide (NAD+) metabolism is essential for maintaining normal physiological activities, and the decreased NAD+ level is related to various pathologies such as cardiac dis

Read more
Autophagy-NAD Axis as a Target for Therapeutic Interventions in NPC1 Disease
Autophagy-NAD Axis as a Target for Therapeutic Interventions in NPC1 Disease

Introduction Targeting the autophagy-NAD axis has been reported be a viable therapeutic strategy for Niemann-Pick type C1 (NPC1) disease. The study suggests that both pharmacological rescue of autophagy deficiency and

Read more
Rh2 and Ca(OH)2 Combo: Promising Treatment for Root Canal Infections
Rh2 and Ca(OH)2 Combo: Promising Treatment for Root Canal Infections

Introduction Apical periodontitis, an inflammatory disease affecting tooth apex tissues, is triggered by oral pathogens infecting the root canal. One of the main reason for endodontic treatment failure is Enterococcus

Read more
The Possible Use of Stevioside as a Therapeutic Alternative in Amoebiasis
The Possible Use of Stevioside as a Therapeutic Alternative in Amoebiasis

Introduction Amoebiasis has emerged as the third most common cause of death by parasites worldwide after malaria and schistosomiasis infections. According to the report of World Health Organization, over 40 milli

Read more
Transcriptome and Metabolome Profiling on the Potential of NMN/NR Against NAFLD
Transcriptome and Metabolome Profiling on the Potential of NMN/NR Against NAFLD

  Introduction Disturbance in hepatic NAD+ metabolism has been manifested as a key factor in the initiation and progression of nonalcoholic fatty liver disease (NAFLD), one of the most co

Read more
Ginsenoside Rg3: A Promising Therapeutic Agent for Traumatic Brain Injury
Ginsenoside Rg3: A Promising Therapeutic Agent for Traumatic Brain Injury

  Introduction According to the 2017 Commission on Traumatic Brain Injury (TBI), TBI remains one of the top three causes of injury-related death and disability up to 2030. There are 50~60

Read more
NMN Supplementation: A Shield Against Doxorubicin-Induced Multi-Organ Fibrosis
NMN Supplementation: A Shield Against Doxorubicin-Induced Multi-Organ Fibrosis

  Introduction In clinical settings, doxorubicin (DOX) is an effective broad-spectrum anti-cancer drug in chemotherapy for various tumors, including hematological malignancies and solid tumors such as leu

Read more
Guarding Your Liver Against Nicotine and Coca-Cola™-Induced Steatosis with NR
Guarding Your Liver Against Nicotine and Coca-Cola™-Induced Steatosis with NR

Introduction Cigarettes containing nicotine (Nic) and sugar-sweetened beverages (SSBs) with high fructose corn syrup (HFCS) have been uncovered to induce hepatic steatosis, which are the risk factors for the developme

Read more
20(S)-Ginsenoside Rh2: A Promising Adjuvant Treatment for Acute Promyelocytic Leukemia
20(S)-Ginsenoside Rh2: A Promising Adjuvant Treatment for Acute Promyelocytic Leukemia

  Introduction Acute promyelocytic leukemia (APL), the M3 type of acute myeloid leukemia (AML), typically relies on all-trans retinoic acid (ATRA) as its primary treatment. While APL patients treated with

Read more

Leave Your Message